Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients

Panopoulou, A, Cairns, DA orcid.org/0000-0002-2338-0179, Holroyd, AE et al. (13 more authors) (2023) Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood, 141 (4). pp. 1666-1674. ISSN 0006-4971

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Keywords: multiple myeloma, lenalidomide, maintenance, molecular markers, prognosis
Dates:
  • Published: 6 April 2023
  • Published (online): 23 December 2022
  • Accepted: 4 December 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 Jan 2023 15:06
Last Modified: 08 Nov 2024 14:46
Status: Published
Publisher: American Society of Hematology
Identification Number: 10.1182/blood.2022018339
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics